New research suggests a ‘tailored vaccine’ might hold the key to treating bacteria-driven flares of eczema in children. The team has taken several leaps forward in understanding how the immune response works in cases of eczema driven by the common, troublesome Staphylococcus aureus bacterium, and in doing so they have identified new cellular targets for a vaccine.